Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACS Group, Inc.PACS · Entity 2590 | Chief Accounting Officer | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACS Group, Inc.
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 355,338 |
Ending reported balance
After 2026-07-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-07-01 · Sale · Disposed 4,200 · Balance 366,138 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-07-02 · Sale · Disposed 6,663 · Balance 359,475 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-07-06 · Sale · Disposed 4,137 · Balance 355,338 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.
F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 06, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 4,137 | $45.04 | $186,332.96 |
DisclosureSEC source: 0002014293-26-000010 · wk-form4_1783378222.xml · nonDerivative · entry 3 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,338 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.15 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 6,663 | $45.03 | $300,032.22 |
DisclosureSEC source: 0002014293-26-000010 · wk-form4_1783378222.xml · nonDerivative · entry 2 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 359,475 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 4,200 | $45.01 | $189,059.22 |
DisclosureSEC source: 0002014293-26-000010 · wk-form4_1783378222.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 366,138 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.06 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 15,000 | $40.01 | $600,178.50 |
DisclosureSEC source: 0002014293-26-000008 · wk-form4_1782511926.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 370,338 F1 · kind: The sale reporting in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.085 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 22:09 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 24,691 | $33.14 | $818,259.74 |
DisclosureSEC source: 0002014293-26-000006 · wk-form4_1776463771.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 385,338 F1 · kind: Payment of tax liability through the withholding of securities upon the vesting of previously granted and reported restricted stock units. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 22:13 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 35,159 | $0.00 | $0.00 |
DisclosureSEC source: 0002014293-26-000004 · wk-form4_1774563220.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 410,029 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:59 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 3,348 | $39.49 | $132,212.52 |
DisclosureSEC source: 0002014293-26-000002 · wk-form4_1768946373.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,870 F1 · kind: Payment of tax liability through the withholding of securities upon the vesting of previously granted and reported restricted stock units. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:36 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 19,127 | $0.00 | $0.00 |
DisclosureSEC source: 0002014293-25-000004 · wk-form4_1766180194.xml · nonDerivative · entry 2 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,218 F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:36 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0002014293-25-000004 · wk-form4_1766180194.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,091 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| April 15, 2025 Filed Apr 16, 2025 23:32 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 16,777 | $9.35 | $156,864.95 |
DisclosureSEC source: 0002001184-25-000022 · wk-form4_1744846343.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 326,591 F1 · kind: Payment of tax liability through the withholding of securities upon the vesting of previously-granted and reported restricted stock units (RSUs). Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 20:01 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 32,012 | $21.00 | $672,252.00 |
DisclosureSEC source: 0001628280-24-016200 · wk-form4_1713211300.xml · nonDerivative · entry 2 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 343,368 Read SEC document |
| April 11, 2024 Filed Apr 15, 2024 20:01 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 375,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-016200 · wk-form4_1713211300.xml · nonDerivative · entry 1 Lewis Michelle Renee · CIK 0002014293 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 375,380 F1 · shares: Represents an award of restricted stock units ("RSUs"), 25% of which vests upon grant and the remainder of which will vest in five substantially equal annual installments thereafter. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.